Ceralifimod

DB16123InvestigationalSmall molecule

Ceralifimod is under investigation in clinical trial NCT01226745 (Phase 2 Extension Trial in Patients With Relapsing-remitting Multiple Sclerosis (RRMS)).

Chemical structure of Ceralifimod
Formula / weight
C27H33NO4 · 435.564 g/mol (avg)

Resolves to

Compound
UNIIBZ2O8A84A4CAS891859-12-4ChEMBLCHEMBL4093489
Clinical / RWD
RxNorm1846443
Structure
InChIKeyQDDQIPUKAXBMBX-UHFFFAOYSA-NSMILESCCCC1=CC=C(COC2=CC3=C(C=C2)C(C)=C(CN2CC(C2)C(O)=O)CC3)C(OC)=C1
Targets
P21453S1PR1

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Ceralifimod, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In